Abbott Receives FDA Clearance for Afinion ™ HbA1c Dx for Diagnosing Diabetes

THE FIRST-EVER POINT-OF-CARE HbA1c ASSAY CLEARED FOR DIAGNOSING DIABETES AND IDENTIFYING PATIENTS AT RISK FOR DIABETES
Source: Abbott.com - Category: Pharmaceuticals Source Type: news